2025
Regeneron Pharmaceuticals's revenue per employee decreased -1% during fiscal
year 2025 compared to 2024.
This represents a decline of -$9.40 K
from $940.16 K (in 2024)
to $930.75 K (in 2025).
... See more
2024
Regeneron Pharmaceuticals's revenue per employee decreased -3.6% during fiscal
year 2024 compared to 2023.
This represents a decline of -$35.10 K
from $975.26 K (in 2023)
to $940.16 K (in 2024).
2023
Regeneron Pharmaceuticals's revenue per employee decreased -5.05% during fiscal
year 2023 compared to 2022.
This represents a decline of -$51.91 K
from $1.03 M (in 2022)
to $975.26 K (in 2023).
2022
Regeneron Pharmaceuticals's revenue per employee decreased -33.74% during fiscal
year 2022 compared to 2021.
This represents a decline of -$522.96 K
from $1.55 M (in 2021)
to $1.03 M (in 2022).
2021
Regeneron Pharmaceuticals's revenue per employee increased 66.43% during fiscal
year 2021 compared to 2020.
This represents an increase of $618.73 K
from $931.39 K (in 2020)
to $1.55 M (in 2021).
2020
Regeneron Pharmaceuticals's revenue per employee increased 15.05% during fiscal
year 2020 compared to 2019.
This represents an increase of $121.81 K
from $809.58 K (in 2019)
to $931.39 K (in 2020).
2019
Regeneron Pharmaceuticals's revenue per employee decreased -10.73% during fiscal
year 2019 compared to 2018.
This represents a decline of -$97.28 K
from $906.86 K (in 2018)
to $809.58 K (in 2019).
2018
Regeneron Pharmaceuticals's revenue per employee decreased -4.25% during fiscal
year 2018 compared to 2017.
This represents a decline of -$40.27 K
from $947.13 K (in 2017)
to $906.86 K (in 2018).
2017
Regeneron Pharmaceuticals's revenue per employee increased 5.23% during fiscal
year 2017 compared to 2016.
This represents an increase of $47.05 K
from $900.08 K (in 2016)
to $947.13 K (in 2017).
2016
Regeneron Pharmaceuticals's revenue per employee decreased -5.69% during fiscal
year 2016 compared to -.
This represents a decline of -$54.28 K
from $954.36 K (in 2015)
to $900.08 K (in 2016).